tiprankstipranks
Palisade Bio initiated with a Buy at Brookline
The Fly

Palisade Bio initiated with a Buy at Brookline

Brookline initiated coverage of Palisade Bio (PALI) with a Buy rating and $38 price target Palisade Bio is advancing novel therapeutics for patients living with autoimmune, inflammatory, and fibrotic diseases, the analyst noted.

Pick the best stocks and maximize your portfolio:

Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>

Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App